Astrocytic EAAT-2 Upregulation Supports Neuro-Axonal Homeostasis in Chronic Inflammatory CNS Lesions
Astrocytic Role in Neuro-Axonal Homeostasis Astrocytes are star-shaped glial cells in the central nervous system (CNS) that play a pivotal […]
Astrocytic Role in Neuro-Axonal Homeostasis Astrocytes are star-shaped glial cells in the central nervous system (CNS) that play a pivotal […]
Case Presentation A 34-year-old female patient with a history of Crohn’s disease, which had previously been managed effectively with infliximab
F-Wave Mechanisms F-waves are a distinct type of electrical wave observed in electromyography (EMG) studies, primarily arising from the activation
Sex Differences in Multiple Sclerosis Multiple sclerosis (MS) is a complex neurological disease characterized by autoimmune pathology that leads to
Single cell landscape of sex differences in the different courses of multiple sclerosis Read Post »
Mechanisms of Hepatic Orosomucoid 2 Hepatic Orosomucoid 2 (ORM2) is a glycoprotein primarily produced by the liver during inflammation and
Hepatic Orosomucoid 2 aggravates demyelination and drives microglial DAM-like activation Read Post »
Patient Demographics In the investigation of chronic inflammatory demyelinating polyneuropathy (CIDP), understanding the demographics of affected patients is essential for
Understanding Pan-neurofascinopathies Pan-neurofascinopathies represent a unique and emerging group of disorders characterized by the dysregulation or malfunction of neurofascin, a
Pan-neurofascinopathies: a subgroup that mimic other neuroimmune-mediated diseases Read Post »
Treatment Patterns and Their Impact The management of pediatric MOG antibody-associated disease involves a variety of therapeutic strategies tailored to
Pathophysiology of Tuberculosis-Associated Myelitis Tuberculosis-associated longitudinally extensive transverse myelitis (LETM) occurs as a result of a complex interplay between the
Tuberculosis-Associated Longitudinally Extensive Transverse Myelitis Read Post »
Study Overview This study investigates the minimal important difference (MID) for the EQ-5D-5L utility values specifically in patients with Chronic